You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百心安-B(02185.HK)擬成立合夥企業開展健康諮詢服務等業務
格隆匯 12-06 22:52

格隆匯12月6日丨 百心安-B(02185.HK)公吿,於2024年12月6日,公司(作為有限合夥人)、國健錦泉(作為普通合夥人兼執行事務合夥人)、保京(作為有限合夥人)就於中國成立有限合夥企業訂立有限合夥協議。根據有限合夥協議,(i)有限合夥企業的資本承擔總額應為人民幣54.30百萬元,其中國健錦泉、公司及保京應分別注資人民幣0.01百萬元、人民幣32.8百萬元及人民幣21.49百萬元,佔注資總額分別約0.0184%、60.4052%及39.5764%。該有限合夥企業將不會作為公司的附屬公司入賬,其財務業績將不會綜合納入集團的綜合財務報表。

有限合夥企業名稱:北京醫創心安科技發展中心(有限合夥)。有限合夥企業的業務範圍包括技術開發、技術推廣、技術轉讓、技術諮詢、技術服務、企業管理、企業管理諮詢、健康諮詢服務(不包括診斷及治療服務)和醫學研究與試驗開發(不包括人類幹細胞、基因診斷及治療技術的開發與應用)。

成立有限合夥企業乃集團投資組合多元化的良機。董事認為,通過與其他合夥人以有限合夥企業的形式進行戰略合作及資源共享,集團將能夠投資於優質投資目標,從而建立一個由擁有不同資本資源、專業知識及技術知識的實體及人員組成的體系,抓住潛在投資機遇,促進集團經濟效益的提高、業務規模的擴大,及盈利能力的最大化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account